A detailed history of Two Sigma Investments, LP transactions in 23and Me Holding Co. stock. As of the latest transaction made, Two Sigma Investments, LP holds 574,803 shares of ME stock, worth $1.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
574,803
Previous 744,946 22.84%
Holding current value
$1.85 Million
Previous $290,000 30.69%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.29 - $0.51 $49,341 - $86,772
-170,143 Reduced 22.84%
574,803 $201,000
Q2 2024

Aug 14, 2024

SELL
$0.36 - $0.61 $223,428 - $378,587
-620,635 Reduced 45.45%
744,946 $290,000
Q1 2024

May 15, 2024

BUY
$0.4 - $0.91 $197,514 - $449,345
493,786 Added 56.64%
1,365,581 $723,000
Q4 2023

Feb 14, 2024

BUY
$0.71 - $0.97 $496,764 - $678,678
699,669 Added 406.49%
871,795 $793,000
Q3 2023

Nov 14, 2023

SELL
$0.96 - $2.01 $899,049 - $1.88 Million
-936,510 Reduced 84.47%
172,126 $168,000
Q2 2023

Aug 14, 2023

SELL
$1.59 - $2.29 $1.08 Million - $1.56 Million
-679,506 Reduced 38.0%
1,108,636 $1.94 Million
Q1 2023

May 15, 2023

BUY
$2.05 - $2.87 $159,492 - $223,288
77,801 Added 4.55%
1,788,142 $4.08 Million
Q4 2022

Feb 14, 2023

BUY
$2.06 - $3.47 $1.17 Million - $1.97 Million
566,903 Added 49.58%
1,710,341 $3.69 Million
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.12 $1.36 Million - $2.67 Million
521,869 Added 83.96%
1,143,438 $3.27 Million
Q2 2022

Aug 15, 2022

SELL
$2.19 - $3.98 $551,218 - $1 Million
-251,698 Reduced 28.82%
621,569 $1.54 Million
Q1 2022

May 16, 2022

BUY
$3.28 - $7.12 $2.86 Million - $6.22 Million
873,267 New
873,267 $3.35 Million

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $834M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.